Eli Lilly Doubles Down On Branded Generics With Novast Expansion In China
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly & Co. announced on March 5 that it will expand its partnership with Novast Laboratories Ltd. by investing $60-70 million to build a manufacturing base at the Novast campus in Nantong, a prefecture 130 kilometers north of Shanghai.